Page 13 - Bharat Biotech

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

The B.1.617 or 'double mutant' Indian variant carries two mutations, including the L452R and E484Q

Covaxin shows 100% efficacy against 'severe Covid-19', 78% overall

The Bharat Biotech candidate has also shown 70 per cent efficacy against asymptomatic infections, suggesting that it prevents transmission

Covid vaccine, price and availability after May 1: All you need to know

In this podcast, we take a look at all those important updates related to coronavirus vaccine in a quick time

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

A new vaccine regime

Govt conducts welcome course correction

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Expanding vaccine supply

Some good moves but freer pricing needed

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

India to increase Covaxin production to 100 mn doses per month by Sept

Currently, 10 mn doses of the indigenous coronavirus vaccine are being produced every month, says govt

Centre clears Mumbai's Haffkine to make Covaxin vaccine as cases rise

In a major step to ramp up vaccine production amid the Covid-19 second wave, the Centre has approved production of Corona vaccines from the Maharashtra government-owned Haffkine Institute in Mumbai

Haffkine Institute gets govt's approval to produce Bharat Biotech's Covaxin

Last month, Uddhav Thackeray had sought central nod to manufacture Bharat Biotech's Covaxin at Haffkine Institute

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

Covid-19 vaccination sites drop to half in India amid shortage of doses

Number of locations down from 120,000 to 60,000 from April 3 to 7

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

Govt's expert panel allows clinical trials for third dose of Covaxin

The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the Covid-19 vaccine, sources said